Epidemiology and clinical characteristics of pathogens positive in hospitalized children with segmental/lobar pattern

Yanxia Wang1, Liji Ma1, Ying Li1

  • 1Pediatrics, Zibo Central Hospital, No. 54, Gongqingtuanxi Street, Zibo City, 255036, Shandong Province, China.

Insights

Mycoplasma pneumoniae is the leading cause of segmental/lobar pneumonia in children, with increasing prevalence over time and in older children. It is linked to extrapulmonary symptoms, unlike Streptococcus pneumoniae which is associated with abnormal WBCs and CRPs.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Microbiology

Background:

  • Segmental/lobar pattern pneumonia (S/L-PP) incidence in children is rising.
  • Changes in antibiotic use and vaccination may alter causative pathogens.
  • Understanding current pathogens and clinical associations in pediatric S/L-PP is crucial.

Purpose of the Study:

  • To identify pathogens in hospitalized children diagnosed with S/L-PP.
  • To analyze the association between identified pathogens and clinical characteristics.

Main Methods:

  • Retrospective analysis of 593 children (<14 years) with S/L-PP from 2014-2018.
  • Pathogen detection via microbial cultivation, indirect immunofluorescence, Elisa, and real-time PCR.
  • Evaluation of epidemiological and clinical data.

Main Results:

  • Mycoplasma pneumoniae (M. pneumoniae) was the most frequent pathogen (72.34%), followed by Streptococcus pneumoniae (S. pneumoniae) (8.77%).
  • M. pneumoniae prevalence increased significantly over the study period and with patient age.
  • M. pneumoniae correlated with extrapulmonary manifestations; S. pneumoniae correlated with abnormal WBCs and CRPs.

Conclusions:

  • M. pneumoniae is the predominant pathogen in pediatric S/L-PP.
  • Increasing trends of M. pneumoniae were observed with time and increasing age.
  • Distinct clinical associations were found for M. pneumoniae (extrapulmonary) and S. pneumoniae (inflammatory markers).
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
650
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
714
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
677
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K